Cargando…

Association between serum angiopoietin-2 concentrations and periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention

Angiopoietin-2 (Ang-2) is a proangiogenic factor that mediates inflammation and atherosclerosis. We evaluated the predictive value of circulating Ang-2 levels for periprocedural myocardial injury (PMI) in 145 patients undergoing elective percutaneous coronary intervention (PCI), and investigated whe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jian, Wen, Guan, Jia-Hui, Zheng, Wen-Bo, Mo, Chang-Hua, Xu, Yu-Tao, Huang, Qi-Li, Wei, Chun-Mei, Wang, Can, Yang, Zhi-Jie, Yang, Guo-Liang, Gui, Chun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138571/ https://www.ncbi.nlm.nih.gov/pubmed/32182213 http://dx.doi.org/10.18632/aging.102936

Ejemplares similares

Periprocedural myocardial and renal injury in patients undergoing elective percutaneous coronary interventions – is there an association?
por: Stipinovic, Mario, et al.
Publicado: (2019)

Association between the magnitude of periprocedural myocardial injury and prognosis in patients undergoing elective percutaneous coronary intervention
por: Zhou, You, et al.
Publicado: (2021)

Relationship of lipoprotein-associated phospholipase A2(Lp-PLA2) and periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention
por: Yin, Yun-jie, et al.
Publicado: (2020)

Serum lipoprotein(a) and risk of periprocedural myocardial injury in patients undergoing percutaneous coronary intervention
por: Huang, Zhuoshan, et al.
Publicado: (2020)

Periprocedural Hemoglobin Changes and Myocardial Injury in Patients Undergoing Percutaneous Coronary Intervention
por: Alizadeh, Keivan, et al.
Publicado: (2013)

Impact of increased inflammation biomarkers on periprocedural myocardial infarction in patients undergoing elective percutaneous coronary intervention: a cohort study
por: Zhao, Liding, et al.
Publicado: (2020)

Serum angiopoietin-2 concentrations of post-PCI are correlated with the parameters of renal function in patients with coronary artery disease
por: Jian, Wen, et al.
Publicado: (2019)

Effects of Percutaneous Coronary Intervention on Serum Angiopoietin-2 in Patients with Coronary Heart Disease
por: Zeng, Zhi-Yu, et al.
Publicado: (2016)

Elevated serum miR-133a predicts patients at risk of periprocedural myocardial injury after elective percutaneous coronary intervention
por: Zhou, You, et al.
Publicado: (2022)

Frequency and outcomes of periprocedural myocardial infarction in patients with chronic coronary syndromes undergoing percutaneous coronary intervention
por: Ueki, Yasushi, et al.
Publicado: (2022)

Elective percutaneous coronary intervention leads to significant changes in serum resistin, leptin, and adiponectin levels regardless of periprocedural myocardial injury: an observational study
por: Buturak, Ali, et al.
Publicado: (2016)

Prognostic value of angiopoietin-2 for patients with coronary heart disease after elective PCI
por: Jian, Wen, et al.
Publicado: (2019)

LDL-C and Total Stent Length are Independent Predictors of Periprocedural Myocardial Injury and Infarction for Unstable Angina Patients Undergoing Elective Percutaneous Coronary Intervention
por: Chen, Xuefeng, et al.
Publicado: (2021)

Predictive Value of Aortic Valve Calcification for Periprocedural Myocardial Injury in Patients Undergoing Percutaneous Coronary Intervention
por: Shibata, Yohei, et al.
Publicado: (2017)

A Simple Clinical Pre-procedure Risk Model for Predicting Thrombocytopenia Associated With Periprocedural Use of Tirofiban in Patients Undergoing Percutaneous Coronary Intervention
por: Yi, Yi-Hu, et al.
Publicado: (2018)

Impact of neutrophil-to-lymphocyte ratio on periprocedural myocardial infarction in patients undergoing non-urgent percutaneous coronary revascularisation
por: Verdoia, M., et al.
Publicado: (2016)

Relationship Between Preoperative Low-Density Lipoprotein Cholesterol and Periprocedural Myocardial Injury in Patients Following Elective Percutaneous Coronary Intervention in Southern China
por: Zhong, Zhixiong, et al.
Publicado: (2018)

Impact of high-density lipoprotein 3 cholesterol subfraction on periprocedural myocardial injury in patients who underwent elective percutaneous coronary intervention
por: Harada, Kazuhiro, et al.
Publicado: (2018)

High-Dose Statin Pretreatment Decreases Periprocedural Myocardial Infarction and Cardiovascular Events in Patients Undergoing Elective Percutaneous Coronary Intervention: A Meta-Analysis of Twenty-Four Randomized Controlled Trials
por: Wang, Le, et al.
Publicado: (2014)

Effects of Shen-Yuan-Dan on Periprocedural Myocardial Injury and the Number of Peripheral Blood Endothelial Progenitor Cells in Patients with Unstable Angina Pectoris Undergoing Elective Percutaneous Coronary Intervention
por: Zhang, Zhenmin, et al.
Publicado: (2022)

Chronic obstructive pulmonary disease and periprocedural complications in patients undergoing percutaneous coronary interventions
por: Januszek, Rafał, et al.
Publicado: (2018)

Impact of multi-vessel therapy to the risk of periprocedural myocardial injury after elective coronary intervention: exploratory study
por: Chen, Zhang-Wei, et al.
Publicado: (2017)

Predictors of periprocedural complications in patients undergoing percutaneous coronary interventions within coronary artery bypass grafts
por: Januszek, Rafał A., et al.
Publicado: (2020)

Coronary plaque morphology on multi-modality imagining and periprocedural myocardial infarction after percutaneous coronary intervention()
por: Sato, Akira, et al.
Publicado: (2016)

Association between NLRP3 inflammasome and periprocedural myocardial injury following elective PCI
por: Chen, Ao, et al.
Publicado: (2023)

Periprocedural temporary pacing in primary percutaneous coronary intervention for patients with acute inferior myocardial infarction
por: Hwang, You Mi, et al.
Publicado: (2016)

Prognostic Impact of Percutaneous Coronary Intervention of Chronic Total Occlusion in Acute and Periprocedural Myocardial Infarction
por: Kim, Seung-Hyun, et al.
Publicado: (2021)

Impact of the Polymorphism rs5751876 of the Purinergic Receptor ADORA2A on Periprocedural Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention
por: Negro, Federica, et al.
Publicado: (2021)

Three-dimensional assessment of coronary high-intensity plaques with T1-weighted cardiovascular magnetic resonance imaging to predict periprocedural myocardial injury after elective percutaneous coronary intervention
por: Hosoda, Hayato, et al.
Publicado: (2020)

Correction to: Three-dimensional assessment of coronary high-intensity plaques with T1-weighted cardiovascular magnetic resonance imaging to predict periprocedural myocardial injury after elective percutaneous coronary intervention
por: Hosoda, Hayato, et al.
Publicado: (2020)

Association between Serum Vitamin D Concentration Status and Matrix Metalloproteinase-9 in Patients Undergoing Elective Percutaneous Coronary Intervention
por: Foroughinia, Farzaneh, et al.
Publicado: (2020)

Exploring the Association of Fibrinogen and CRP with the Clinical Spectrum of CAD and Periprocedural Outcomes in Patients Undergoing Percutaneous Coronary Interventions
por: Khandelwal, Vijay, et al.
Publicado: (2022)

Long-term outcomes of periprocedural coronary dissection and perforation for patients undergoing percutaneous coronary intervention in a Japanese multicenter registry
por: Kuno, Toshiki, et al.
Publicado: (2023)

COlchicine to Prevent PeriprocEdural Myocardial Injury in Percutaneous Coronary Intervention (COPE-PCI): Coronary Microvascular Physiology Pilot Substudy
por: Cole, Justin, et al.
Publicado: (2022)

Angiopoietin‐2 provides no incremental predictive value for the presence of obstructive coronary artery disease over N‐terminal pro‐brain natriuretic peptide
por: Jian, Wen, et al.
Publicado: (2019)

Relationship between Pre-Procedural Serum Lipid Profile and Post-Procedural Myocardial Injury in Patients Undergoing Elective Percutaneous Coronary Intervention
por: Maadani, Mohsen, et al.
Publicado: (2013)

Total Thrombus‐formation Analysis System Predicts Periprocedural Bleeding Events in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
por: Oimatsu, Yu, et al.
Publicado: (2017)

Positive Association of Coronary Calcium Detected by Computed Tomography Coronary Angiography with Periprocedural Myocardial Infarction
por: Wang, Xinguo, et al.
Publicado: (2013)

Relationship of High‐Density Lipoprotein Cholesterol With Periprocedural Myocardial Injury Following Elective Percutaneous Coronary Intervention in Patients With Low‐Density Lipoprotein Cholesterol Below 70 mg/dL
por: Li, Xiao‐Lin, et al.
Publicado: (2015)

Risk Factors of Periprocedural Bradycardia during Primary Percutaneous Coronary Intervention in Patients with Acute ST-Elevation Myocardial Infarction
por: Li, Yong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0o2aipllfscso90qigehep0lj1